Ignite Creation Date:
2024-05-05 @ 5:24 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00444314
Status:
COMPLETED
Last Update Posted:
2011-08-04
First Post:
2007-03-06
Brief Title:
Phase 2 Study of Panzem NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell Carcinoma
Sponsor:
Organization:
CASI Pharmaceuticals Inc